Current antimicrobial therapy of anaerobic infections
- 1 November 1992
- journal article
- review article
- Published by Springer Nature in European Journal of Clinical Microbiology & Infectious Diseases
- Vol. 11 (11) , 999-1011
- https://doi.org/10.1007/bf01967790
Abstract
No abstract availableKeywords
This publication has 71 references indexed in Scilit:
- Results of a Multicenter Trial Comparing Imipenem/Cilastatin to Tobramycin/Clindamycin for Intra-abdominal InfectionsAnnals of Surgery, 1990
- In vitro activity of meropenem (SM-7338), imipenem, and five other antibiotics against anaerobic clinical isolatesDiagnostic Microbiology and Infectious Disease, 1990
- In vitro comparison of cefoperazone/sulbactam with selected antimicrobials against 300 bacteroides isolatesDiagnostic Microbiology and Infectious Disease, 1989
- Mechanisms of resistance in anaerobes and new developments in testingDiagnostic Microbiology and Infectious Disease, 1989
- Factors predisposing to seizures in seriously III infected patients receiving antibiotics: Experience with imipenem/cilastatinThe American Journal of Medicine, 1988
- Effect of clavulanic acid on the susceptibility of clinical anaerobic bacteria to ticarcillin: A multicenter studyDiagnostic Microbiology and Infectious Disease, 1988
- A Randomized Controlled Trial of Ampicillin plus Sulbactam vs. Gentamicin plus Clindamycin in the Treatment of Intraabdominal Infections: A Preliminary ReportClinical Infectious Diseases, 1986
- Mechanisms of β-Lactam Resistance in Anaerobic BacteriaClinical Infectious Diseases, 1986
- Bacteroides fragilis resistant to both metronidazole and imipenemJournal of Antimicrobial Chemotherapy, 1986
- Variation in the potentiation of β-lactam antibiotic activity by clavulanic acid and sulbactam against multiply antibiotic-resistant bacteriaJournal of Antimicrobial Chemotherapy, 1986